0001411579-25-000073
SEC filingAMC's Q3 2025 results declined YoY due to a weaker film slate, but the nine-month trend improved; liquidity remains a concern.
For the three months ended September 30, 2025, AMC reported total revenues of $1.30B, a decrease of 3.6% YoY from $1.35B. The decline was driven by a 3.9% drop in admissions revenue ($715.1M vs $744.2M) and a 7.9% fall in food & beverage revenue ($451.8M vs $490.4M), both due to a 10.3% decrease in attendance (58.4M vs 65.1M patrons). Average ticket prices increased 7.2%, and food & beverage per patron rose 2.8% to $7.74, partially offsetting volume declines. Other theatre revenue increased 16.7% to $133.3M, aided by higher advertising income from an amended exhibitor services agreement.
Operating income plunged 50.1% to $35.8M, as operating costs only fell 1.0%, reflecting fixed cost deleverage. Film exhibition costs as a percentage of admissions improved to 49.3% from 51.2%, but operating expenses rose 2.2% as a percentage of revenue (35.7% vs 33.7%). Net loss widened to $298.2M from $20.7M, primarily due to $196.0M in debt extinguishment losses on refinancing transactions, compared to a prior-year net gain from debt transactions and other income.
For the nine-month period, revenues grew 6.9% to $3.56B, with admissions up 6.1% and attendance up 0.8%. Operating loss improved to $(17.5)M from $(84.0)M, and net loss increased to $(505.0)M from $(217.0)M, reflecting the impact of debt extinguishment charges.
U.S. Markets: Revenues fell 4.7% in Q3, with a 5.0% decline in admissions on a 9.9% attendance drop, offset by a 5.5% increase in average ticket price. Market share gains from loyalty initiatives and discount days provided partial support. Operating income dropped to $45.7M from $74.5M, as operating expenses rose 2.3% and rent increased 1.7%. For the nine months, U.S. revenues rose 6.9%, and operating income turned positive at $35.9M vs $(25.5M) in the prior year.
International Markets: Revenues were essentially flat (+0.3%) in Q3. Admissions fell 11.4% but average ticket price rose 12.4% (boosted by FX). Operating loss widened to $(9.9)M from $(2.7)M, impacted by rent (+9.0%) and general & administrative costs. Nine-month revenues increased 6.9% with an operating loss improvement to $(53.4)M from $(58.5)M, helped by government assistance and package ticket expirations.
Management reiterates that current cash burn rates are not sustainable long-term. Revenues need to increase to at least pre-COVID-19 levels (North American box office down ~22% vs 2019) to achieve net positive cash flows. Capital expenditures for FY2025 are estimated at $175M–$225M. The company completed significant debt refinancing in Q3 2025, including the issuance of $857.0M in New 2029 Notes and $194.4M in New Exchangeable Notes. No formal revenue or profit guidance was provided. Risks include film release schedule uncertainty, changing consumer behavior, and the need for additional liquidity beyond the next twelve months.
For the nine months ended September 30, 2025, the company reported a net loss of $505.0M, yet cash used in operating activities was $246.5M. The significant non-cash items include depreciation and amortization ($233.3M), loss on debt extinguishment ($196.0M), PIK interest ($28.7M), and stock-based compensation ($17.7M), partially offset by gains on derivatives ($52.1M) and deferred rent ($82.6M). The working capital changes were mixed: receivables decreased by $68.8M (favorable) but accounts payable declined by $119.9M (unfavorable). Overall, the operating cash flow deficit narrowed by 3.1% from $254.4M in the prior period.
Capital expenditures increased to $162.7M from $155.8M, indicating ongoing investment in theatres. Interest paid was $285.5M, and no dividends or share repurchases were reported. The financing activities provided $134.3M, driven by net equity issuances of $169.6M and proceeds from Senior Secured Notes ($244.4M), offset by debt repayments and fees. The free cash flow (not explicitly stated) is negative when combining CFO and capex.
Anomalies include the $196.0M loss on debt extinguishment and significant non-cash financing activities such as debt exchanges. The company's cash and restricted cash declined by $263.9M to $416.9M.